Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022496
Filing Date
2017-11-08
Accepted
2017-11-08 08:01:12
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q neot-10q_20170930.htm 10-Q 898259
2 EX-31.1 neot-ex311_7.htm EX-31.1 18942
3 EX-32.1 neot-ex321_6.htm EX-32.1 9914
  Complete submission text file 0001564590-17-022496.txt   3470073

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT neot-20170930.xml EX-101.INS 659532
5 XBRL TAXONOMY EXTENSION SCHEMA neot-20170930.xsd EX-101.SCH 33767
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neot-20170930_cal.xml EX-101.CAL 29517
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neot-20170930_def.xml EX-101.DEF 96573
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neot-20170930_lab.xml EX-101.LAB 255863
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neot-20170930_pre.xml EX-101.PRE 185012
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 270 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 270 SAN DIEGO CA 92122 (858) 750-1008
Neothetics, Inc. (Filer) CIK: 0001618835 (see all company filings)

EIN.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 171185133
SIC: 2834 Pharmaceutical Preparations